ATE347106T1 - Diagnose von karzinomen mit hilfe des raig1- polypeptids - Google Patents

Diagnose von karzinomen mit hilfe des raig1- polypeptids

Info

Publication number
ATE347106T1
ATE347106T1 AT03717443T AT03717443T ATE347106T1 AT E347106 T1 ATE347106 T1 AT E347106T1 AT 03717443 T AT03717443 T AT 03717443T AT 03717443 T AT03717443 T AT 03717443T AT E347106 T1 ATE347106 T1 AT E347106T1
Authority
AT
Austria
Prior art keywords
polypeptide
cancer
carcinoma
diagnosis
expression
Prior art date
Application number
AT03717443T
Other languages
English (en)
Inventor
J A Terrett
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0208331.9A external-priority patent/GB0208331D0/en
Priority claimed from GB0221538A external-priority patent/GB0221538D0/en
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of ATE347106T1 publication Critical patent/ATE347106T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03717443T 2002-04-11 2003-04-10 Diagnose von karzinomen mit hilfe des raig1- polypeptids ATE347106T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0208331.9A GB0208331D0 (en) 2002-04-11 2002-04-11 Proteins
GB0221538A GB0221538D0 (en) 2002-09-17 2002-09-17 A protein involved in carcinoma

Publications (1)

Publication Number Publication Date
ATE347106T1 true ATE347106T1 (de) 2006-12-15

Family

ID=29252443

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03717443T ATE347106T1 (de) 2002-04-11 2003-04-10 Diagnose von karzinomen mit hilfe des raig1- polypeptids

Country Status (8)

Country Link
US (2) US20050282165A1 (de)
EP (1) EP1497656B1 (de)
JP (2) JP2005522226A (de)
AT (1) ATE347106T1 (de)
AU (1) AU2003222606A1 (de)
DE (1) DE60310059T2 (de)
ES (1) ES2274220T3 (de)
WO (1) WO2003087832A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004001060A2 (en) * 2002-06-20 2003-12-31 Bristol-Myers Squibb Company Identification and regulation of a g-protein coupled receptor, rai-3
WO2021045224A1 (ja) * 2019-09-04 2021-03-11 国立大学法人東海国立大学機構 がん免疫療法等における免疫関連有害事象の予測

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068618A1 (en) * 2000-07-26 2003-04-10 Muralidharu Padigaru Novel proteins and nucleic acids encoding same
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2002059271A2 (en) * 2001-01-25 2002-08-01 Gene Logic, Inc. Gene expression profiles in breast tissue
WO2003000012A2 (en) * 2001-06-21 2003-01-03 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer

Also Published As

Publication number Publication date
JP2005522226A (ja) 2005-07-28
AU2003222606A1 (en) 2003-10-27
US20090258019A1 (en) 2009-10-15
WO2003087832A3 (en) 2004-02-12
JP2010117358A (ja) 2010-05-27
WO2003087832A2 (en) 2003-10-23
US20050282165A1 (en) 2005-12-22
EP1497656A2 (de) 2005-01-19
DE60310059T2 (de) 2007-05-10
EP1497656B1 (de) 2006-11-29
AU2003222606A8 (en) 2003-10-27
ES2274220T3 (es) 2007-05-16
DE60310059D1 (de) 2007-01-11

Similar Documents

Publication Publication Date Title
EP1124846A4 (de) Nukleotid- und proteinsequenzen von nogo-genen und darauf beruhende methoden
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
DE69926731D1 (de) Diagnose und behandlung von aur1 und/oder aur2 verwandten erkrankungen
ATE519847T1 (de) Il-17-homologe polypeptide und ihre therapeutische verwendung
DE69839123D1 (de) Prostattumor polynukleotid- und antigenzusammensetzungen
AU4929701A (en) Whole-body optical imaging of gene expression and uses thereof
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
DE69926764D1 (de) Methoden zur bestimmung von komponenten zur modulation des körpergewichts
GB0324656D0 (en) A protein involved in ovarian cancer
MXPA05007940A (es) Composiciones y metodos para el tratamiento del cancer usando igsf9 y liv-1.
ATA192799A (de) Neue verwendung von antikörpern als impfstoffe
ATE347106T1 (de) Diagnose von karzinomen mit hilfe des raig1- polypeptids
EA200501711A1 (ru) Семейство секретируемых белков
WO2003087840A3 (en) Protein involved in cancer
TR200102655T2 (tr) Dört L. infantum proteininin antijen belirleyicilerini kodlayan kimerik gen.
WO2002092765A3 (en) Novel telomerase inhibitors and uses therefor
DE60113968D1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
EA200700951A1 (ru) БЕЛКИ, СОДЕРЖАЩИЕ ДОМЕНЫ vWFA И/ИЛИ ANT_IG
WO2001064876A3 (en) Human schizophrenia gene
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
DE60018964D1 (de) Diagnose und behandlung von krebs unter verwendung von sgp28-ähnlichen molekülen
NZ512332A (en) Potassium channel interactors and uses therefor
ATE329027T1 (de) Menschliches leucinereiche wiederholungen enthaltendes protein, vorwiegend im dünndarm exprimiert, hlrrsi1
ATE298244T1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties